Ohio State’s Glen Barber named to Citation Laureates 2025 for Nobel-class research with global impact
COLUMBUS – Glen Barber, PhD, is a Citation Laureates 2025 for his groundbreaking cancer research.
He is one of 22 researchers from around the world selected by the experts at the Institute for Scientific Information (ISI) at Clarivate Plc for pioneering contributions that are shaping the future of science and society.
Since the program’s inception, 83 Citation Laureates have gone on to receive Nobel Prizes, often years after their initial recognition by Clarivate.
“It’s a great honor to be acknowledged for our efforts, along with the other laureates,” said Barber, director of the Center for Innate Immunity and Inflammation at The Ohio State University Comprehensive Cancer Center’s Pelotonia Institute for Immuno-Oncology, associate director for entrepreneurship and technology commercialization at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and professor in the Division of Surgical Oncology at The Ohio State University College of Medicine. “To have your work deemed as affecting such an impact globally is indeed gratifying – a researcher’s aspiration.”
Citation Laureates’ foundational research papers rank among the most highly cited in their fields, reflecting exceptional influence across disciplines and borders. This year’s Laureates have advanced knowledge in fields of urgent global relevance, including physiology or medicine, physics, chemistry and economics.
Barber’s research focuses on understanding innate immunity – the body’s natural defenses against viruses and cancer. His team endeavors to find the origin of infectious, inflammatory and cancer-associated diseases. It also focuses on the development of cancer treatments that use viruses to infect and kill cancer cells, and ways to help the body’s immune system avoid inflammation while fighting cancer and microbial infection.
“Each year, the Citation Laureates program highlights researchers whose work has transformed their disciplines and delivered profound societal impact,” said Emmanuel Thiveaud, senior vice president for Research & Analytics, Academia & Government at Clarivate. “Their research is not only highly cited but deeply influential. At Clarivate, we are proud to honor these pioneers whose contributions often foreshadow Nobel recognition and help shape a better future.”
The 2025 Laureates are affiliated with leading academic institutions in eight countries/regions. Ten are based in the United States, three in France, two each in Germany, Japan, and Switzerland, and one each in Canada, the Netherlands and China.
Since 2002, ISI analysts have used publication and citation data from the Web of Science Core Collection to identify potential Nobel Prize recipients. Out of 64 million articles and proceedings indexed since 1970, less than 0.02 percent have been cited more than 2,000 times.
The Citation Laureates program does not aim to predict Nobel Prize recipients in a specific year. It highlights researchers whose work is of Nobel class and deserving of global recognition.
To learn more about the Pelotonia Institute for Immuno-Oncology, visit cancer.osu.edu/PIIO.